You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

unresectable

Showing 1 - 25 of 4,751
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unresectable Pancreatic Cancer, Unresectable Bile Duct Carcinoma, Unresectable Biliary Tract Carcinoma Trial (Tripegfilgrastim)

Not yet recruiting
  • Unresectable Pancreatic Cancer
  • +2 more
  • (no location specified)
Nov 13, 2023

Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Yttrium-90 carbon microspheres SIRT
  • Nanjing, China
    Gao-Jun Teng
Jul 20, 2023

Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

Not yet recruiting
  • Locally Advanced Unresectable Pancreatic Adenocarcinoma
  • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
  • (no location specified)
Jun 25, 2023

Unresectable Hepatocellular Carcinoma, Oligometastatic Disease Trial in Beijing (SBRT plus tislelizumab and regorafenib)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Oligometastatic Disease
  • SBRT plus tislelizumab and regorafenib
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2023

Unresectable Pancreatic Cancer Trial (creon 35.000 Ph.U (R), Best Standarard of Care)

Not yet recruiting
  • Unresectable Pancreatic Cancer
  • creon 35.000 Ph.U (R)
  • Best Standarard of Care
  • (no location specified)
Oct 19, 2023

Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)

Recruiting
  • Unresectable/Metastatic Colorectal Cancer
  • Fruquintinib plus camrelizumab and capecitabine
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 19, 2023

Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)

Recruiting
  • Unresectable or Metastatic Colorectal Cancer
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Mar 22, 2023

Hepatocellular Carcinoma Trial in Shanghai (M-TACE)

Enrolling by invitation
  • Hepatocellular Carcinoma
  • M-TACE
  • Shanghai, Shanghai, China
    Department of Interventional Radiology, Zhongshan Hospital, Fuda
May 24, 2023

Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

Not yet recruiting
  • Unresectable Metastatic Colorectal Cancer
  • (no location specified)
Oct 25, 2023

Unresectable Gallbladder Cancer Trial in Guangzhou (Carrilizumab plus GEMOX)

Not yet recruiting
  • Unresectable Gallbladder Cancer
  • Carrilizumab plus GEMOX
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 16, 2023

Hepatocellular Carcinoma Non-resectable Trial in Taoyuan City (Atezolizumab, Bevacizumab, Proton radiotherapy)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Taoyuan City, Taiwan
    Chang Gung Memorial Hospital at Linkou
Nov 17, 2023

Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive

Not yet recruiting
  • Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
  • Non-investigational
  • (no location specified)
May 11, 2023

Colon Cancer Liver Metastases Trial (sequential adult left lateral lobe liver transplantation (SALT))

Not yet recruiting
  • Colon Cancer Liver Metastases
  • sequential adult left lateral lobe liver transplantation (SALT)
  • (no location specified)
Oct 3, 2023

Metastatic Breast Cancer, Unresectable Breast Cancer Trial in Saint Louis (DiviTum® TKa assay, CDK4/6 + Endocrine therapy)

Not yet recruiting
  • Metastatic Breast Cancer
  • Unresectable Breast Cancer
  • DiviTum® TKa assay
  • CDK4/6 + Endocrine therapy
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2023

Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon

Recruiting
  • Unresectable Colorectal Liver Metastases
  • Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
  • Nanjing, Jiangsu, China
    Zhongda Hospital Southeast University
Jan 26, 2023

Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)

Not yet recruiting
  • Unresectable Intrahepatic Cholangiocarcinoma
  • (no location specified)
Feb 17, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

Completed
  • Colorectal Cancer Metastatic
  • Targeted agent
  • (no location specified)
Aug 31, 2023

Unresectable Pancreatic Cancer Trial in Baltimore (NanoKnife IRE System)

Active, not recruiting
  • Unresectable Pancreatic Cancer
  • NanoKnife IRE System
  • Baltimore, Maryland
    University of Maryland Medical Center
Jan 30, 2023

Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable

Recruiting
  • Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8
  • +2 more
  • Best Practice
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib, sintilimab plus SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 8, 2023

Unresectable Hepatocellular Carcinoma Trial in Changsha (Donafenib Tosilate Tablets, Toripalimab Injection)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Donafenib Tosilate Tablets
  • Toripalimab Injection
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Nov 28, 2022

Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 18, 2023

Patterns of Transcatheter Arterial Chemoembolization Combined

Not yet recruiting
  • HCC
  • (no location specified)
Aug 29, 2023